MRF-Logo2019-Horizontal-RGB
Re: I could REALLY use some advice/encouragement
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Re: I could REALLY use some advice/encouragement

› Forums › General Melanoma Community › I could REALLY use some advice/encouragement › Re: I could REALLY use some advice/encouragement

    • August 17, 2010 at 8:08 pm
    EmilyandMike
    Participant

      Pam – forgot to mention – not sure if you had a complete lymph node dissection or not.  If you do, you would be eligible for the ipilimumab trial as adjuvant therapy after surgery.  But you need to sign up within 8-12 weeks after surgery.  Mike would have done this trial but he didnt qualify due to the amount of cells in his sentinel node (too little),   BUT the trial is blind so you will not know for sure if you get the drug unless you get the side effects.  Ipi side effects seem to be way less than Interferon.

    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics